Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The "monoamine oxidase substrate pool" refers to the collection of endogenous monoamines—primarily noradrenaline (norepinephrine), other catecholamines (such as dopamine), and serotonin—that serve as substrates for the enzyme monoamine oxidase (MAO). MAO exists in two isoforms, MAO-A and MAO-B, both of which are mitochondrial flavoenzymes responsible for catalyzing the oxidative deamination of these neurotransmitters. By degrading neurotransmitters such as noradrenaline, dopamine, and serotonin in neural tissues—and also acting on dietary amines systemically—MAOs regulate synaptic levels of these signaling molecules. This regulation is crucial for mood balance, cardiovascular function, stress response, cognition, and more. The availability—and physiological effects—of these biogenic amines are directly regulated by this enzymatic pathway through either natural turnover or pharmacological manipulation.
Levels of noradrenaline/catecholamines/serotonin decrease or increase depending on MAO activity or inhibition, impacting neuropsychiatric symptoms or causing hypertensive crises.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Monoamine Oxidase Substrate Pool (None).